Institute of Medical Microbiology and Hygiene, University of Mainz Medical Centre, Mainz, Germany.
Department of Internal Medicine and Cardiology, Campus Benjamin Franklin, Charité - Universitätsmedizin, Berlin, Germany.
Semin Immunopathol. 2018 Feb;40(2):145-156. doi: 10.1007/s00281-017-0658-5. Epub 2017 Nov 9.
The mucosal immune system and the microbiota in the intestinal tract have recently been shown to play a key role in the pathogenesis of inflammatory bowel disease (IBD). Both of these can be influenced by food. Thus, we propose dietary intervention as a therapeutic option for IBD. In this review, we discuss the interaction of the intestinal mucosal immune system and the intestinal microbiota in the context of IBD. In addition, we discuss the impact of food components on immune responses in IBD. Finally, we address the current evidence of how this interaction (i.e., immune system-microbiota) can be modulated by food components, pre/probiotics, and fecal microbiota transplantation (FMT) and how these approaches can support intestinal homeostasis. By gathering the vast amount of literature available on the impact of food on IBD, we aim to distinguish between scientifically sound data and theories, which have not been included in this review.
肠道黏膜免疫系统和肠道微生物群最近被证明在炎症性肠病(IBD)的发病机制中发挥关键作用。这两者都可以受到食物的影响。因此,我们提出饮食干预作为 IBD 的治疗选择。在这篇综述中,我们讨论了肠道黏膜免疫系统和肠道微生物群在 IBD 背景下的相互作用。此外,我们还讨论了食物成分对 IBD 中免疫反应的影响。最后,我们探讨了目前关于食物成分、益生菌和粪便微生物群移植(FMT)如何通过这种相互作用(即免疫系统-微生物群)来调节的证据,以及这些方法如何支持肠道内稳态。通过收集大量关于食物对 IBD 影响的文献,我们旨在区分有科学依据的数据和理论,这些内容未包含在本综述中。